← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 20, 2021Last known activity
Aug 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 5 trials)
Phase 2 (3 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Recent trials (11)
- NCT07128251CollaboratorPhase 2Aug 20, 2025
- NCT06063941CollaboratorN/AOct 10, 2023
- NCT06015113Overall official - principal investigatorN/ASep 30, 2023
- NCT06015113Reponsible party - principal investigatorN/ASep 30, 2023
- NCT06015113Lead sponsorN/ASep 30, 2023
- NCT06015126Lead sponsorN/AOct 5, 2022
- NCT06015126Overall official - principal investigatorN/AOct 5, 2022
- NCT06015126Sponsor investigatorN/AOct 5, 2022
- NCT06015100Lead sponsorN/AFeb 20, 2021
- NCT06015100Sponsor investigatorN/AFeb 20, 2021
- NCT06015100Overall official - principal investigatorN/AFeb 20, 2021
Details
- Last known activity
- Aug 20, 2025